VEGF Gene Transfer for Diabetic Polyneuropathy: A Randomized Double Blinded Trial

OBJECTIVE: Phase 2 randomized trial of intramuscular gene transfer using plasmid vascular endothelial growth factor (VEGF) to treat diabetic polyneuropathy. METHODS: Diabetics with polyneuropathy and no neoplasm or active retinopathy were randomized to receive VEGF:placebo 3:1. Three sets of injecti...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ann Neurol
Main Authors: Ropper, Allan H., Gorson, Kenneth C., Gooch, Clifton L., Weinberg, David H., Pieczek, Ann, Ware, James H., Kershen, Joshua, Rogers, Adam, Simovic, Drasko, Schratzberger, Peter, Kirchmair, Rudolf, Losordo, Douglas
Formato: Artigo
Idioma:Inglês
Publicado em: 2009
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4709012/
https://ncbi.nlm.nih.gov/pubmed/19399887
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ana.21675
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados